3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
40
Recurrence
3
Smoldering Multiple Myeloma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasms, Plasma Cell
2
Neoplasms
2
Immunoglobulin Light-chain Amyloidosis
2
Renal Insufficiency
1
Purpura
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Paraproteinemias
1
Neoplasm, Residual
1
Nausea
1
Natural Killer/T-cell Lymphoma
1
Macroglossia
1
Lymphoproliferative Disorders
1
Lymphoma
1
Lymphadenopathy
1
Leukemia, Plasma Cell
1
Leukemia, Myeloid, Acute
1
Immunoproliferative Disorders
1
Hepatomegaly
1
Hematologic Neoplasms
1
Gastrointestinal Hemorrhage
1
Diarrhea
1
Constipation
1
Interventions
Cyclophosphamide
43
venetoclax
30
Cytarabine
25
fludarabine
22
fludarabine phosphate
17
Azacitidine
16
Mycophenolic Acid
13
Whole-Body Irradiation
12
Dexamethasone
12
Rituximab
11
Busulfan
11
ruxolitinib
10
Vincristine
10
Methotrexate
10
Etoposide
10
Tacrolimus
9
Mercaptopurine
9
Daunorubicin
9
Prednisone
8
Filgrastim
8
Dasatinib
8
ibrutinib
7
Peripheral Blood Stem Cell Transplantation
7
Melphalan
7
Granulocyte Colony-Stimulating Factor
7
Doxorubicin
7
Decitabine
7
pegaspargase
6
blinatumomab
6
Mesna
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia
×
isatuximab
×
1 year
×
Clear all
No trials found.